PE3-036 Long Term Outcome of Atrioventricular Node Ablation with Pacemaker in Patients with Atrial Fibrillation

Sang Weon Park, Ji Eun Ban, Yae Min Park, Jongil Choi, Young Hoon Kim

Research output: Contribution to journalArticle

Abstract

This study was to investigated the long term outcome of Atrioventricular node (AVN) ablation with implantation of a permanent pacemaker (PPM) in patients with atrial fibrillation (AF). Methods: Twenty one patients (59.2±13.8 years) who underwent AVN ablation with implantation of PPM were studied. We divided study population into two group-according to history of catheter ablation (CA) for AF to assess predictors to affect clinical outcome. Results: Seven patients underwent CA for AF before procedure and 14 patients without CA were identified. All but 3 patients had normal left ventricular (LV) systolic function. Indication of AVN ablation with implantation of PPM was AF with slow (n=5) or fast (n=4) ventricular response and AF with sick sinus syndrome in 12 (57.1%). Mean age at procedure was younger (55.8±17.0 years) in prior ablation group than no CA group (61 ±12.2 years, P<0.001) and mean symptom duration to procedure was significantly shorter in CA group (5.8 ± 8.5 months vs, 12.8 ± 9.7 months, P=0.02). In 11 patients (52.4%), symptoms were still ongoing. CA group demonstrated higher incidence of symptom as compared with no CA group (85.7% vs 41.7%, P=0.06). Conclusions: AVN ablation with PPM implantation is less effective to relief of symptoms. The younger age and shorter symptom duration to procedure were associated with higher incidence of symptomatic clinical outcome.

Original languageEnglish
Number of pages1
JournalJournal of Arrhythmia
Volume27
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Atrioventricular Node
Catheter Ablation
Atrial Fibrillation
Sick Sinus Syndrome
Incidence
Ventricular Fibrillation
Left Ventricular Function
Population

Keywords

  • atrial fibrillation
  • atrioventricular node ablation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

PE3-036 Long Term Outcome of Atrioventricular Node Ablation with Pacemaker in Patients with Atrial Fibrillation. / Park, Sang Weon; Ban, Ji Eun; Park, Yae Min; Choi, Jongil; Kim, Young Hoon.

In: Journal of Arrhythmia, Vol. 27, 01.01.2011.

Research output: Contribution to journalArticle

@article{f626623db035413d8909f010066472db,
title = "PE3-036 Long Term Outcome of Atrioventricular Node Ablation with Pacemaker in Patients with Atrial Fibrillation",
abstract = "This study was to investigated the long term outcome of Atrioventricular node (AVN) ablation with implantation of a permanent pacemaker (PPM) in patients with atrial fibrillation (AF). Methods: Twenty one patients (59.2±13.8 years) who underwent AVN ablation with implantation of PPM were studied. We divided study population into two group-according to history of catheter ablation (CA) for AF to assess predictors to affect clinical outcome. Results: Seven patients underwent CA for AF before procedure and 14 patients without CA were identified. All but 3 patients had normal left ventricular (LV) systolic function. Indication of AVN ablation with implantation of PPM was AF with slow (n=5) or fast (n=4) ventricular response and AF with sick sinus syndrome in 12 (57.1{\%}). Mean age at procedure was younger (55.8±17.0 years) in prior ablation group than no CA group (61 ±12.2 years, P<0.001) and mean symptom duration to procedure was significantly shorter in CA group (5.8 ± 8.5 months vs, 12.8 ± 9.7 months, P=0.02). In 11 patients (52.4{\%}), symptoms were still ongoing. CA group demonstrated higher incidence of symptom as compared with no CA group (85.7{\%} vs 41.7{\%}, P=0.06). Conclusions: AVN ablation with PPM implantation is less effective to relief of symptoms. The younger age and shorter symptom duration to procedure were associated with higher incidence of symptomatic clinical outcome.",
keywords = "atrial fibrillation, atrioventricular node ablation",
author = "Park, {Sang Weon} and Ban, {Ji Eun} and Park, {Yae Min} and Jongil Choi and Kim, {Young Hoon}",
year = "2011",
month = "1",
day = "1",
doi = "10.4020/jhrs.27.PE3_036",
language = "English",
volume = "27",
journal = "Journal of Arrhythmia",
issn = "1880-4276",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - PE3-036 Long Term Outcome of Atrioventricular Node Ablation with Pacemaker in Patients with Atrial Fibrillation

AU - Park, Sang Weon

AU - Ban, Ji Eun

AU - Park, Yae Min

AU - Choi, Jongil

AU - Kim, Young Hoon

PY - 2011/1/1

Y1 - 2011/1/1

N2 - This study was to investigated the long term outcome of Atrioventricular node (AVN) ablation with implantation of a permanent pacemaker (PPM) in patients with atrial fibrillation (AF). Methods: Twenty one patients (59.2±13.8 years) who underwent AVN ablation with implantation of PPM were studied. We divided study population into two group-according to history of catheter ablation (CA) for AF to assess predictors to affect clinical outcome. Results: Seven patients underwent CA for AF before procedure and 14 patients without CA were identified. All but 3 patients had normal left ventricular (LV) systolic function. Indication of AVN ablation with implantation of PPM was AF with slow (n=5) or fast (n=4) ventricular response and AF with sick sinus syndrome in 12 (57.1%). Mean age at procedure was younger (55.8±17.0 years) in prior ablation group than no CA group (61 ±12.2 years, P<0.001) and mean symptom duration to procedure was significantly shorter in CA group (5.8 ± 8.5 months vs, 12.8 ± 9.7 months, P=0.02). In 11 patients (52.4%), symptoms were still ongoing. CA group demonstrated higher incidence of symptom as compared with no CA group (85.7% vs 41.7%, P=0.06). Conclusions: AVN ablation with PPM implantation is less effective to relief of symptoms. The younger age and shorter symptom duration to procedure were associated with higher incidence of symptomatic clinical outcome.

AB - This study was to investigated the long term outcome of Atrioventricular node (AVN) ablation with implantation of a permanent pacemaker (PPM) in patients with atrial fibrillation (AF). Methods: Twenty one patients (59.2±13.8 years) who underwent AVN ablation with implantation of PPM were studied. We divided study population into two group-according to history of catheter ablation (CA) for AF to assess predictors to affect clinical outcome. Results: Seven patients underwent CA for AF before procedure and 14 patients without CA were identified. All but 3 patients had normal left ventricular (LV) systolic function. Indication of AVN ablation with implantation of PPM was AF with slow (n=5) or fast (n=4) ventricular response and AF with sick sinus syndrome in 12 (57.1%). Mean age at procedure was younger (55.8±17.0 years) in prior ablation group than no CA group (61 ±12.2 years, P<0.001) and mean symptom duration to procedure was significantly shorter in CA group (5.8 ± 8.5 months vs, 12.8 ± 9.7 months, P=0.02). In 11 patients (52.4%), symptoms were still ongoing. CA group demonstrated higher incidence of symptom as compared with no CA group (85.7% vs 41.7%, P=0.06). Conclusions: AVN ablation with PPM implantation is less effective to relief of symptoms. The younger age and shorter symptom duration to procedure were associated with higher incidence of symptomatic clinical outcome.

KW - atrial fibrillation

KW - atrioventricular node ablation

UR - http://www.scopus.com/inward/record.url?scp=85008730729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008730729&partnerID=8YFLogxK

U2 - 10.4020/jhrs.27.PE3_036

DO - 10.4020/jhrs.27.PE3_036

M3 - Article

VL - 27

JO - Journal of Arrhythmia

JF - Journal of Arrhythmia

SN - 1880-4276

ER -